1.Male or female, age â?¥ 18 to â?¤ 65 years <br/ >2.Subject (or legally authorized representative) provides informed consent prior to initiation and comply with planned study procedures. <br/ >3.Has laboratory-confirmed SARS-CoV-2 infection as determined by polymerase chain reaction (PCR) <br/ >4.Illness of Moderate severity <br/ >

1.Male or female, age â?¥ 18 to â?¤ 65 years <br/ >2.Subject (or legally authorized representative) provides informed consent prior to initiation and comply with planned study procedures. <br/ >3.Has laboratory-confirmed SARS-CoV-2 infection as determined by polymerase chain reaction (PCR) <br/ >4.Illness of Moderate severity <br/ >

1.Male or female, age â?¥ 18 to â?¤ 65 years <br/ >2.Subject (or legally authorized representative) provides informed consent prior to initiation and comply with planned study procedures. <br/ >3.Has laboratory-confirmed SARS-CoV-2 infection as determined by polymerase chain reaction (PCR) <br/ >4.Illness of Moderate severity <br/ >

1.Male or female, age â?¥ 18 to â?¤ 65 years <br/ >2.Subject (or legally authorized representative) provides informed consent prior to initiation and comply with planned study procedures. <br/ >3.Has laboratory-confirmed SARS-CoV-2 infection as determined by polymerase chain reaction (PCR) <br/ >4.Illness of Moderate severity <br/ >